Literature DB >> 2563116

Fulminant hepatitis due to cyproterone acetate.

H Lévesque, C Trivalle, N D Manchon, J P Vinel, N Moore, J Hémet, H Courtois, E Bercoff, J Bourreille.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2563116     DOI： 10.1016/s0140-6736(89)91225-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Toxic hepatitis after sequential administration of flutamide and cyproterone acetate.

Authors:  Spilios Manolakopoulos; Sotirios Bethanis; Anastasios Armonis; Michalis Economou; Alec Avgerinos; Dimitrios Tzourmakliotis
Journal:  Dig Dis Sci       Date:  2004-03       Impact factor: 3.199

2.  Hepatic failure induced by cyproterone acetate: A case report and literature review.

Authors:  Jae Heon Kim; Byung Wook Yoo; Won Jae Yang
Journal:  Can Urol Assoc J       Date:  2014-05       Impact factor: 1.862

Review 3.  Fatal fulminant hepatic failure due to cyproterone acetate.

Authors:  G Friedman; E Lamoureux; A H Sherker
Journal:  Dig Dis Sci       Date:  1999-07       Impact factor: 3.199

Review 4.  Hepatotoxicity induced by cyproterone acetate: a report of three cases.

Authors:  Ioanna Savidou; Melanie Deutsch; Aspasia S Soultati; Dimitrios Koudouras; Georgia Kafiri; Spyridon P Dourakis
Journal:  World J Gastroenterol       Date:  2006-12-14       Impact factor: 5.742

5.  Severe hepatitis caused by cyproterone acetate.

Authors:  J C Blake; A M Sawyerr; J S Dooley; P J Scheuer; N McIntyre
Journal:  Gut       Date:  1990-05       Impact factor: 23.059

Review 6.  Cyproterone. A review of its pharmacology and therapeutic efficacy in prostate cancer.

Authors:  L B Barradell; D Faulds
Journal:  Drugs Aging       Date:  1994-07       Impact factor: 3.923
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.